Medicity Medichem Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 23-10-2024
- Paid Up Capital ₹ 0.10 M
as on 23-10-2024
- Company Age 6 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.15 Cr
as on 23-10-2024
- Revenue 38.47%
(FY 2023)
- Profit -18.05%
(FY 2023)
- Ebitda 36.29%
(FY 2023)
- Net Worth 19.15%
(FY 2023)
- Total Assets 55.39%
(FY 2023)
About Medicity Medichem
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.15 Cr.
Rajesh Choudhary and Kamla Choudhary serve as directors at the Company.
- CIN/LLPIN
U51900MH2018PTC310009
- Company No.
310009
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 May 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Raigarh, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Medicity Medichem?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Choudhary  | Managing Director | 28-May-2018 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kamla Choudhary | Director | 28-May-2018 | Current |
Financial Performance of Medicity Medichem.
Medicity Medichem Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 38.47% increase. The company also saw a substantial fall in profitability, with a 18.05% decrease in profit. The company's net worth Soared by an impressive increase of 19.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medicity Medichem?
In 2023, Medicity Medichem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Medigrowth Pharmaceuticals Private LimitedActive 4 years 4 months
Rajesh Choudhary is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 Jun 2023 | ₹2.00 Cr | Open |
Others Creation Date: 03 Dec 2022 | ₹1.15 Cr | Open |
Hdfc Bank Limited Creation Date: 02 Mar 2021 | ₹1.00 Cr | Open |
How Many Employees Work at Medicity Medichem?
Medicity Medichem has a workforce of 10 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medicity Medichem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medicity Medichem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
